Ferritin Levels in Chronic Kidney Disease

Introduction to Ferritin in CKD

Ferritin levels are frequently elevated in CKD patients independent of actual iron stores, primarily because ferritin functions as an acute-phase reactant that rises during inflammation, which is common in CKD 1, 2

Inflammation drives ferritin elevation independent of iron stores - In hemodialysis patients, ferritin can be markedly elevated even when actual tissue iron stores are normal or low 1, 2
Ferritin increases during acute inflammatory states and infections, making it unreliable as a sole measure of iron status 3, 4

Ferritin levels up to 500-700 ng/mL may still represent functional iron deficiency when inflammation is present 1, 2
Consider measuring C-reactive protein to assess the inflammatory contribution to elevated ferritin 1, 2
Transferrin saturation is more reliable than ferritin for assessing iron availability in CKD because it is less affected by inflammation 1, 2
Ferritin <25 ng/mL (males) or <11 ng/mL (females) indicates true iron deficiency 1, 2
Elevated ferritin in the presence of low transferrin saturation suggests inflammatory iron block rather than adequate iron stores 5, 1

Functional iron deficiency: Serial ferritin levels decrease during erythropoietin therapy but remain >100 ng/mL 5
Inflammatory iron block: Abrupt increase in ferritin associated with sudden drop in transferrin saturation 5
Trial approach: Give weekly IV iron (50-125 mg) for 8-10 doses - if no erythropoietic response occurs, inflammatory block is most likely and further iron should be withheld until inflammation resolves 5

Recent guidelines suggest maintaining ferritin <500 ng/mL in non-dialysis CKD and using proactive iron strategies in hemodialysis patients unless ferritin exceeds 700 ng/mL 6

The American Journal of Kidney Diseases recommends target ferritin levels for dialysis patients receiving erythropoiesis-stimulating agents (ESAs) should maintain ferritin >200 ng/mL and TSAT >20% to optimize erythropoiesis and reduce ESA requirements 7, 8
Upper safety thresholds recommend avoiding chronic maintenance of ferritin >800 ng/mL in hemodialysis patients, though levels between 300-800 ng/mL have been common without evidence of adverse iron-mediated effects 7
Hemodialysis patients already lose blood through repetitive dialyzer-related losses, making additional blood removal through venesection harmful and unnecessary 7
No physiologic rationale exists for reducing ferritin to normal ranges in ESRD patients, as they require higher iron stores to compensate for ongoing losses and support ESA therapy 7

Venesection guidelines apply to hemochromatosis, where the target is ferritin <50 µg/L, which is completely inappropriate for ESRD patients who require higher ferritin levels (>200 ng/mL) to support erythropoiesis 9, 10
The European Association for the Study of the Liver recommends that hemochromatosis management (which targets ferritin <50 µg/L through venesection) should not be applied to ESRD patients—these are completely different clinical contexts 9, 10

The National Kidney Foundation recommends that serum ferritin levels between 300-800 ng/mL are not inherently harmful in dialysis patients and do not indicate iron overload 11, 12, 13
The American College of Physicians suggests that the upper safety threshold for ferritin is avoiding chronic maintenance of ferritin >800 ng/mL, though the exact level at which iron overload occurs remains unknown 11, 12
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines indicate that there is a risk associated with failure to use IV iron because many patients will be anemic unless they receive it, and anemia is associated with increased morbidity and mortality 12, 13

The National Institute of Diabetes and Digestive and Kidney Diseases recommends targeting iron indices, including maintaining ferritin >200 ng/mL and TSAT >20% to optimize erythropoiesis and reduce ESA requirements in hemodialysis patients on ESAs 14
The American Society of Nephrology suggests avoiding chronically maintaining ferritin >800 ng/mL in hemodialysis patients 11, 12
The European Renal Association - European Dialysis and Transplant Association recommends monitoring both ferritin AND TSAT together with hemoglobin levels and ESA dose to determine the need for iron therapy 15, 14

The American Journal of Kidney Diseases recommends checking TSAT and ferritin at least every 3 months in stable patients 11, 15
The Kidney International Supplements suggests that IV iron doses of 100-125 mg or less per week do not need to be interrupted for accurate iron parameter measurement 15